US pharma major Eli Lilly, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive top-line ...

The New Drug Application (NDA) for the combination of Elunate (fruquintinib) and TYVYT (sintilimab injection) has been ...

Genesis Molecular AI and Incyte announced a new kind of deal, with Incyte’s proprietary experimental data powering ...

Bayer has announced that the US Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) and granted Priority Review designation for Kerendia (finerenone), which is ...

The UK subsidiary of Japan’s Otsuka (TYO: 4578) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Dawnzera (donidalorsen) for the routine prevention ...

US rare disease drugmaker BioMarin (Nasdaq: BMRN) said its growth disorder therapy Voxzogo (vosoritide) met the primary endpoint in a pivotal Phase III study in children with hypochondroplasia, ...

A preclinical biotech company based in Wilmington, Delaware, focused on developing CAR‑T cell immunotherapies to treat severe allergic conditions. Founded in 2022, the company leverages novel CAR‑T ...

For much of the past decade, biotech companies sold investors on scale and future potential. Discovery engines, synthetic biology platforms, gene-editing systems and AI-led pipelines were presented as ...

A Hong Kong–listed biotechnology company focused on the discovery, development and commercialization of small-molecule and peptide therapeutics. Ascletis Pharma develops medicines across metabolic ...

Scenic Biotech has progressed enormously since it was founded in 2017 as a spin-out from the Netherlands Cancer Institute and ...

American States are rolling out complex drug price-setting efforts - but there is no evidence yet that patients are or will ...

A clinical-stage Israeli biotech advancing steroid-free therapies for ocular diseases, with a lead program in Phase III ...